Journal article
Is there a role for small molecule metabolite biomarkers in the development of a diagnostic test for endometriosis?
Systems Biology in Reproductive Medicine, Vol.68(2), pp.89-112
2022
Abstract
Endometriosis is a disease defined by the presence of benign lesions of endometrial-like glands and stroma outside the endometrial cavity. Affecting an estimated 11.4% of Australian women, symptoms include chronic pelvic pain, dysmenorrhea and infertility. The current gold standard of diagnosis requires an expensive and invasive laparoscopic surgery, resulting in delayed time to treatment. The identification of a non-invasive endometriosis biomarker – a measurable factor correlating with disease presence or activity – has therefore become a priority in endometriosis research, although no biomarker has yet been validated. As small molecule metabolites and lipids have emerged as a potential focus, this review with systematic approach, aims to summarize studies examining metabolomic biomarkers of endometriosis in order to guide future research. EMBASE, PubMed and Web of Science were searched using keywords: lipidomics OR metabolomics OR metabolome AND diagnostic tests OR biomarkers AND endometriosis, and only studies written in English from August 2000 to August 2020 were included. Twenty-nine studies met inclusion and exclusion criteria and were included. These studies identified potential biomarkers in serum, ectopic tissue, eutopic endometrium, peritoneal fluid, follicular fluid, urine, cervical swabs and endometrial fluid. Glycerophospholipids were identified as potential biomarkers in all specimens, except urine and cervical swab specimens. However, no individual molecule or metabolite combination has reached clinical diagnostic utility. Further research using large study populations with robust patient phenotype and specimen characterisation is required if we are to make progress in identifying and validating a non-invasive diagnostic test for endometriosis.
Details
- Title
- Is there a role for small molecule metabolite biomarkers in the development of a diagnostic test for endometriosis?
- Authors/Creators
- N.E. Tomkins (Author/Creator)J.E. Girling (Author/Creator)B. Boughton (Author/Creator)S.J. Holdsworth-Carson (Author/Creator)
- Publication Details
- Systems Biology in Reproductive Medicine, Vol.68(2), pp.89-112
- Publisher
- Taylor & Francis
- Identifiers
- 991005545112407891
- Murdoch Affiliation
- Australian National Phenome Centre
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
82 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.128 Fertility, Endometriosis & Hysterectomy
- 1.128.1075 Endometriosis
- Web Of Science research areas
- Andrology
- Reproductive Biology
- ESI research areas
- Clinical Medicine